FDA Inspection
South Texas Blood & Tissue CenterSouth Texas Blood & Tissue Center – FDA Inspection, Aug 14, 2025
Record Details
This FDA Inspection record concerns South Texas Blood & Tissue Center, with an inspection on August 14, 2025, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · eb0b438b-63e2-4a2c-862f-51cdae99b320
Inspection Facts
- Inspection number
- 1279560
- FDA center
- Biologics
Other FDA inspections of South Texas Blood & Tissue Center
12| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 20, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 14, 2020 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for South Texas Blood & Tissue Center
- FDA Inspection 1172990 - 2022-06-09
- FDA Inspection 1122018 - 2020-02-20
- FDA Inspection 1117859 - 2020-02-14
- FDA Inspection 1057467 - 2018-06-19
- FDA Inspection 1021713 - 2017-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.